367 related articles for article (PubMed ID: 12395224)
1. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
Franz IW; Van Der Meyden J; Schaupp S; Tönnesmann U
Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
Holverda S; Bogaard HJ; Groepenhoff H; Postmus PE; Boonstra A; Vonk-Noordegraaf A
Respiration; 2008; 76(2):160-7. PubMed ID: 17960052
[TBL] [Abstract][Full Text] [Related]
4. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
Dernaika TA; Beavin M; Kinasewitz GT
Respiration; 2010; 79(5):377-82. PubMed ID: 19786728
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.
Sajkov D; Wang T; Frith PA; Bune AJ; Alpers JA; McEvoy RD
Chest; 1997 Jun; 111(6):1622-30. PubMed ID: 9187185
[TBL] [Abstract][Full Text] [Related]
6. Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease.
Umehara M; Yamaguchi A; Itakura S; Suenaga M; Sakaki Y; Nakashiki K; Miyata M; Tei C
J Cardiol; 2008 Apr; 51(2):106-13. PubMed ID: 18522783
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators.
Burger CD
COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms.
Kanazawa H; Tateishi Y; Yoshikawa J
Clin Physiol Funct Imaging; 2004 Jul; 24(4):224-8. PubMed ID: 15233837
[TBL] [Abstract][Full Text] [Related]
9. [Influence of pulmonary hemodynamics on right ventricular ejection fraction in chronic obstructive pulmonary disease].
Steiner S; Peters AJ; Schwalen A; Leschke M; Perings C; Strauer BE
Pneumologie; 1999 May; 53(5):249-54. PubMed ID: 10414141
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
Adnot S; Samoyeau R; Weitzenblum E
Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
[TBL] [Abstract][Full Text] [Related]
11. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
12. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Lee TM; Chen CC; Shen HN; Chang NC
Clin Sci (Lond); 2009 Mar; 116(6):497-505. PubMed ID: 18831711
[TBL] [Abstract][Full Text] [Related]
13. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.
Bertoli L; Fusco M; Lo Cicero S; Micallef E; Busnardo I
Postgrad Med J; 1986; 62 Suppl 1():47-51. PubMed ID: 3022273
[TBL] [Abstract][Full Text] [Related]
14. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
Gassner A
Schweiz Med Wochenschr; 1984 Mar; 114(10):332-7. PubMed ID: 6710104
[TBL] [Abstract][Full Text] [Related]
15. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine in hypertension: its effects on platelet aggregation and dynamic exercise.
Hernández R; Carvajal AR; Armas-de Hernande MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S25-7. PubMed ID: 16296703
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment.
Lampert E; Tuo N; Frans A; Lonsdorfer J
Pathol Biol (Paris); 1991 Jan; 39(1):29-33. PubMed ID: 2011406
[TBL] [Abstract][Full Text] [Related]
20. [Effects of captopril on hemodynamics, gas exchange and exercise capacity in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Paitl CE; Nery LE; Romaldini H; Herrmann JL; Portugal OP; dos Santos ML; Martinez Filho EE
Arq Bras Cardiol; 1989 Feb; 52(2):59-67. PubMed ID: 2688602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
